📰Breast cancer treatment option, olaparib recommended by NICE. Around 1,200 people are set to benefit from olaparib, for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy. Learn more: https://www.nice.org.uk/guidance/ta1040?utm_medium=organic&utm_source=whatsapp&utm_campaign=olaparib&utm_content=finalvideo